LISDEXAMFETAMINE 30 MG TB CHEW

lisdexamfetamine dimesylate
$4.7633per EA
DEA Schedule CII

Strength

30 mg/1

NDC

31722032301

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA217068

On Market Since

8/25/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-5.3%

3M

-21.0%

6M

-32.7%

1Y

-37.1%

3Y

N/A

5Y

N/A

All

-37.1%